American Kidney Fund Applauds Groundbreaking and Crucial Passage of Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Recipients By the U.S. House of Representatives
December 11, 2020
December 11, 2020
ROCKVILLE, Maryland, Dec. 11 (TNSJou) -- The American Kidney Fund issued the following statement:
* * *
The following statement may be attributed to LaVarne A. Burton, president and CEO of the American Kidney Fund:
"The American Kidney Fund (AKF) applauds Reps. Ron Kind (D-WI), Jason Smith (R-MO) and Michael Burgess (R-TX), and all Ambassadors in the AKF Advocacy Network for their work in securing U.S. House of Representatives passage of legislation gi . . .
* * *
The following statement may be attributed to LaVarne A. Burton, president and CEO of the American Kidney Fund:
"The American Kidney Fund (AKF) applauds Reps. Ron Kind (D-WI), Jason Smith (R-MO) and Michael Burgess (R-TX), and all Ambassadors in the AKF Advocacy Network for their work in securing U.S. House of Representatives passage of legislation gi . . .